|
| Press Releases |
|
 |
|
| Monday, September 25, 2023 |
|
|
致力于开发中国双抗疗法的生物技术公司武汉友芝友生物于香港联交所主板正式挂牌 |
| 武汉友芝友生物制药股份有限公司（“友芝友生物”、或 “公司”，连同其附属公司，统称“集团”；股份代号：2496.HK），今天上午9时正于香港联合交易所有限公司（“联交所”）主板正式上市并开始买卖。 more info >> |
|
|
致力於開發中國雙抗療法的生物技術公司武漢友芝友生物於香港聯交所主板正式掛牌 |
| 武漢友芝友生物製藥股份有限公司（「友芝友生物」或 「公司」，連同其附屬公司，統稱「集團」；股份代號：2496.HK），今天上午9時正於香港聯合交易所有限公司（「聯交所」）主板正式上市並開始買賣。 more info >> |
|
A biotechnology company dedicated to developing BsAb-based therapies in China, YZY Biopharma Officially Listed on Main Board of SEHK
|
| Wuhan YZY Biopharma Co., Ltd. ("YZY Biopharma" or the "Company", together with its subsidiaries, the "Group", stock code: 2496.HK), is officially listed and commenced trading on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK") today. more info >> |
|
| Wednesday, September 13, 2023 |
|
|
专注于中国双抗的开发 武汉友芝友生物宣布于港交所主板上市计划 |
| 武汉友芝友生物制药股份有限公司（“友芝友生物”或“公司”，连同其附属公司，统称“集团”；股份代号：2496.HK），一家致力于开发用于治疗癌症相关并发症、癌症及老年性眼科疾病的基于双特异性抗体（双抗）疗法的生物技术公司，今天宣布于香港联合交易所有限公司（“联交所”）主板上市计划。 more info >> |
|
|
專注於中國雙抗的開發 武漢友芝友生物宣佈於港交所主板上市計劃 |
| 武漢友芝友生物製藥股份有限公司（「友芝友生物」或 「公司」，連同其附屬公司，統稱「集團」；股份代號：2496.HK），一家致力於開發用於治療癌症相關併發症、癌症及老年性眼科疾病的基於雙特異性抗體（雙抗）療法的生物技術公司，今天宣佈於香港聯合交易所有限公司（「聯交所」）主板上市計劃。 more info >> |
|
|
Focusing on the development of BsAbs in China, YZY Biopharma Announces Proposed Listing on the Main Board of SEHK |
| Wuhan YZY Biopharma Co., Ltd. ("YZY Biopharma" or the "Company", together with its subsidiaries, the "Group", stock code: 2496.HK), a biotechnology company dedicated to developing bispecific antibody (BsAb)-based therapies to treat cancer-associated complications more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Global News and Publishing Platform Gnomi Launches Paid Journalism Program
May 13, 2024 23:15 HKT/SGT
|
|
|
Creation Business Consultants Expands Presence with New Office in Hong Kong
May 13, 2024 20:20 HKT/SGT
|
|
|
$9.25 Million in Investments Committed to Start-ups during FinTech World Cup at Dubai FinTech Summit
May 13, 2024 19:58 HKT/SGT
|
|
|
富士通、スーパーコンピュータ「富岳」の世界ランキング結果を発表
May 13, 2024 19:00: JST
|
|
|
Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings
May 13, 2024 18:32 JST
|
|
|
Eisai's Antiepileptic Drug Fycompa Approved in China for Adjunctive Treatment of Primary Generalized Tonic-Clonic Seizures
May 13, 2024 17:06 JST
|
|
|
Datacloud APAC: Charting the Course for APAC's Cloud Future
May 13, 2024 16:00 HKT/SGT
|
|
|
Creation Business Consultants Expands Presence with New Office in Hong Kong
May 13, 2024 15:30 HKT/SGT
|
|
|
Thailand: Ivy launches plum and tamarind juice drinks in SIG XSlimBloc carton packs
May 13, 2024 15:00 HKT/SGT
|
|
|
3rd Annual Clean Power & New Energy 2024
May 13, 2024 14:03 HKT/SGT
|
|
|
Ogier and TOYOTA GAZOO Racing triumph again
May 13, 2024 14:36 JST
|
|
|
日清食品公布2024年首季度业绩
May 13, 2024 13:00 HKT/SGT
|
|
|
日清食品公布2024年首季度業績
May 13, 2024 12:57 HKT/SGT
|
|
|
Spa points haul for TOYOTA GAZOO Racing
May 13, 2024 13:56 JST
|
|
|
Nissin Foods Announces 2024 Q1 Financial Results
May 13, 2024 12:52 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
